Trump Rejects Proposal for Medicare to Cover Wegovy and Other Obesity Drugsnews2025-04-04T23:42:16+00:00April 4th, 2025|The New York Times|
Dr. Oz: How His Millions Collide With Medicarenews2025-02-24T10:00:29+00:00February 24th, 2025|The New York Times|
As Drugstores Close, Older People Are Left in ‘Pharmacy Deserts’news2024-12-21T13:12:05+00:00December 21st, 2024|The New York Times|
Drug Companies Face Hostility as They Hope for Allies Among Trump’s Health Picksnews2024-11-28T02:32:29+00:00November 28th, 2024|The New York Times|
Obesity Drugs Would Be Covered by Medicare and Medicaid Under Biden Proposalnews2024-11-26T21:15:23+00:00November 26th, 2024|The New York Times|
The Campaign Issue That Isn’t: Health Care Reformnews2024-09-13T09:01:07+00:00September 13th, 2024|The New York Times|
The State That Chose to Cover Obesity Drugs for Its Poor, but Not Its Own Employeesnews2024-08-30T14:12:23+00:00August 30th, 2024|The New York Times|
Algunos estados en EE. UU. afirman que no pueden costear Ozempic y otros medicamentos para perder pesonews2024-06-29T16:11:41+00:00June 29th, 2024|The New York Times|
Some States Say They Can’t Afford Ozempic and Other Weight Loss Drugsnews2024-06-25T21:09:10+00:00June 25th, 2024|The New York Times|
